Human papillomavirus type 16 (HPV-16) viral load and persistence of HPV-16 infection in women infected or at risk for HIV

Journal of Clinical Virology

Volumn 43, Issue 3, 2008, Pages 307-312

  Fontaine, Julie ^a,b   Hankins, Catherine ^b,c   Money, Deborah ^d   Rachlis, Anita ^e   Pourreaux, Karina ^c   Ferenczy, Alex ^f   Coutlée, François ^a,b  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^f MCGILL UNIVERSITY   (Canada)

Author keywords

CIN; HIV; HPV; HPV 16; Viral load

Indexed keywords

CELL DNA;

ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN PAPILLOMAVIRUS TYPE 16; INFECTION RISK; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; VIRUS LOAD;

ADOLESCENT; ADULT; AGED; CD4 LYMPHOCYTE COUNT; CHILD; FEMALE; HIV INFECTIONS; HUMAN PAPILLOMAVIRUS 16; HUMANS; LONGITUDINAL STUDIES; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; RISK FACTORS; VAGINA;

EID: 53849105056     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2008.07.013     Document Type: Article

References (50)

1. de Sanjose S., and Palefsky J. Cervical and anal HPV infections in HIV positive women and men. Virus Res 89 (2002) 201-211
2. Snijders P.J., Steenbergen R.D.M., Heideman D.A.M., and Meijer C.J.L.M. HPV-mediated cervical carcinogenesis: current concepts and clinical implications. J Pathol 208 (2006) 152-164
3. Ellerbrock T.V., Chiasson M.A., Bush T.J., Sun X.W., Sawo D., Brudney K., et al. Incidence of cervical squamous intraepithelial lesions in HIV-infected women. JAMA 283 (2000) 1031-1037
4. Jamieson D.J., Duerr A., Burk R., Klein R.S., Paramsothy P., Schuman P., et al. HIV ERS. Characterization of genital human papillomavirus infection in women who have or who are at risk of having HIV infection. Am J Obstet Gynecol 186 (2002) 21-27
5. Hawes SE, Critchlow CW, Niang MAF, Diouf MB, Diop A, Toure P, Kasse AA, Dembele B, Sow PS, Coll Seck AM, Kuypers JM, Kiviat NB. Increased risk of high-grade cervical squamous intraepithelial lesions and invasive cervical cancer among African women with human immunodeficiency virus type 1 and 2 infections. J Infect Dis 2003;188(August(4)):555.
6. Moscicki A, Ellenberg JH, Farhat S, Xu J. Persistence of human papillomavirus infection in HIV-related and -uninfected adolescent girls: risk factors and differences, by phylogenetic type. J Infect. Dis 2004;190(July(1)):37-45.
7. Rowhani Rahbar A., Hawes S.E., Sow P.S., Toure P., Feng Q., Dem A., et al. The impact of HIV status and type on the clearance of human papillomavirus infection among Senegalese women. J Infect Dis 196 (2007) 887-894
8. Sun X.W., Kuhn L., Ellerbrock T.V., Chiasson M.A., Bush T.J., and Wright Jr. T.C. Human papillomavirus infection in women infected with the human immunodeficiency virus. New Engl J Med 337 (1997) 1343-1349
9. Ahdieh L., Klein R.S., Burk R., Cu-Uvin S., Schuman P., Duerr A., et al. Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women. J Infect Dis 184 (2001) 682-690
10. Minkoff H., Feldman J., DeHovitz J., Landesman S., and Burk R. A longitudinal study of human papillomavirus carriage in human immunodeficiency virus-infected and human immunodeficiency virus-uninfected women. Am J Obstet Gynecol 178 (1998) 982-986
11. Schlecht N.F., Kulaga S., Robitaille J., Ferreira S., Santos M., Miyamura R.A., et al. Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. JAMA 286 (2001) 3106-3114
12. Wang S.S., and Hildesheim A. Viral and host factors in human papillomavirus persistence and progression. J Natl Cancer Inst Monogr (2003) 35-40
13. Ferenczy A., and Franco E.L. Persistent human papillomavirus infection and cervical neoplasia. Lancet Oncology 3 (2002) 11-16
14. Ylitalo N., Sorensen P., Josefsson A.M., Magnusson P.K.E., Anderson P.K., Ponten J., et al. Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study. Lancet 355 (2000) 2194-2198
15. Flores R., Papenfuss M., Klimecki W.T., and Giuliano A.R. Cross-sectional analysis of oncogenic HPV viral load and cervical intraepithelial neoplasia. Int J Cancer 118 (2006) 1187-1193
16. Tsai H.T., Wu C.H., Lai H.L., Li R.N., Tung Y.C., Chuang H.Y., et al. Association between quantitative high-risk human papillomavirus DNA load and cervical intraepithelial neoplasm risk. Cancer Epidemiol Biomarkers Prevent 14 (2005) 2544-2549
17. Rajeevan M.S., Swan D.C., Nisenbaum R., Lee D.R., Vernon S.D., Ruffin M.T., et al. Epidemiologic and viral factors associated with cervical neoplasia in HPV-16-positive women. Int J Cancer 115 (2005) 114-120
18. Nobbenhuis M.A., Walboomers J.M., Helmerhorst T.J., Rozendaal L., Remmink A.J., Risse E.K., et al. Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Lancet 354 (1999) 20-25
19. Lefevre J., Hankins C., Pourreaux K., Coutlée F., and The Canadian Women's HIV study Group. Human papillomavirus Type 16 viral load is increased in HIV-seropositive women with high-grade squamous intraepithelial lesions compared to those with normal cytology smears. J Clin Microbiol 42 (2004) 2212-2215
20. Shah K.V., Solomon L., Daniel R., Cohn S., and Vlahov D. Comparison of PCR and Hybrid capture methods for detection of human papillomavirus in injection drug-using women at high risk of human immunodeficiency virus infection. J Clin Microbiol 35 (1997) 517-519
21. Weissenborn S.J., Funke A.M., Hellmich M., Mallmann P., Fuschs P.G., Pfister H.J., et al. Oncogenic Humn papillomavirus DNA loads in human immunodeficiency virus-positive women with High-grade cervical lesions are strongly elevated. J Clin Microbiol 41 (2003) 2763-2767
22. Fontaine J., Hankins C., Mayrand M.H., Lefevre J., Money D., Gagnon S., et al. High levels of episomal and integrated HPV-16 DNA are associated with high-grade cervical lesions in women at risk or infected with HIV. AIDS 19 (2005) 785-794
23. Villa L.L., Sichero L., Rahal P., Caballero O., Ferenczy A., Rohan T., et al. Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. J Gen Virol 81 (2000) Pt 12:2959-68
24. Schlecht N.F., Trevisan A., Duarte-Franco E., Rohan T.E., Ferenczy A., Villa L.L., et al. Viral load as a predictor of the risk of cervical intraepithelial neoplasia. Int J Cancer 103 (2003) 519-524
25. Hankins C., et al. Prevalence of risk factors associated with human papillomavirus infection in women living with HIV. Can Med Ass J 160 (1999) 185-191
26. Hankins C., et al. Participation in clinical trials among women living with HIV in Canada. Can Med Ass J 159 (1998) 1359-1365
27. Coutlée F., Hankins C., Lapointe N., Gill J., Romanowski B., Shafran S., et al. Comparison betwen vaginal tampon and cervicovaginal lavage specimens collection for detection of human papillomavirus DNA by the polymerase chain reaction. J Med Virol 51 (1997) 42-47
28. Hildesheim A., Schiffman M.H., Gravitt P.E., Glass A.G., Greer C.E., Zhang T., et al. Persistence of type-specific human papillomavirus infection among cytologically normal women. J Inf Dis 169 (1994) 235-240
29. Azizi N, Brazete J, Hankins C, Money D, Fontaine J, Koushik A, et al. Influence of HPV-16 E2 polymorphism on quantitation of HPV-16 episomal and integrated DNA in cervicovaginal lavages from women with cervical intraepithelial neoplasia. J Gen Virol, in press.
30. Lefevre J., et al. Real-time PCR assays using internal Controls for quantitation of HPV-16 and β-globin DNA in cervicovaginal lavages. J Virol Methods 144 (2003) 135-144
31. Peitsaro P., Johansson B., and Syrjanen S. Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real-time PCR technique. J Clin Microbiol 40 (2002) 886-891
32. Lefevre J., Hankins C., Pourreaux K., Coutlée F., and The Canadian Women's HIV study Group. Prevalence of selective inhibition of HPV-16 DNA amplification in cervicovaginal lavages. J Med Virol 72 (2004) 132-137
33. Swan D.C., Tucker R.A., Tortolero-Luna G., Mitchell M.F., Wideroff L., Unger E.R., et al. Human papillomavirus (HPV) DNA copy number is dependent on grade of cervical disease and HPV type. J Clin Microbiol 37 (1999) 1030-1034
34. Gravitt P.E., Peyton C., Wheeler C., Apple R., Higuchi R., and Shah K.V. Reproducibility of HPV 16 and HPV 18 viral load quantitation using TaqMan real-time PCR assays. J Virol Methods 112 (2003) 23-33
35. Yamada T., Manos M.M., Peto J., Greer C.E., Munoz N., Bosch F.X., et al. Human papillomavirus type 16 sequence variation in cervical cancers-a worlwide perspective. J Virol 71 (1997) 2463-2472
36. Franco E.L., Villa L.L., Sobrinho J.P., Prado J.M., Rousseau M.-C., Désy M., et al. Epidemiology of acquisition and clearance of cervical Human Papillomavirus infection in women from a high-risk area for cervical cancer. J Inf Dis 180 (1999) 1415-1423
37. Ho G.Y.F., Bierman R., Beardsley L., Chang C.J., and Burk R.D. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 338 (1998) 423-428
38. Hawes S.E., Critchlow C.W., Faye N.M., Diouf M.B., Diop A., Toure P., et al. Increased risk of high-grade cervical squamous intraepithelial lesions and invasive cervical cancer among African women with human immunodeficiency virus type 1 and 2 infections. J Inf Dis 188 (2003) 555-563
39. Denny L., Boa R., Williamson A.L., Allan B., Hardie D., Stan R., et al. Human papillomavirus infection and cervical disease in human immunodeficiency virus-1-infected women. Obstet Gynecol 111 (2008) 1380-1387
40. Lorincz A.T., Castle P.E., Sherman M.E., Scott D.R., Glass A.G., Wacholder S., et al. Viral load of human papillomavirus and risk of CIN3 or cervical cancer. Lancet 360 (2002) 228-229
41. Josefsson A.M., Magnusson P.K.E., Ylitalo N., Sorensen P., Qwarforth-Tubbin P., Anderson P.K., et al. Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study. Lancet 355 (2000) 2189-2193
42. Womack S.D., Chirenje Z.M., Gaffikin L., Blumenthal P.D., McGrath J.A., Chipato T., et al. HPV-based cervical cancer screening in a population at high risk for HIV infection. Int J Cancer 85 (2000) 206-210
43. van Duin M., Snidjers P.J.F., Schrijnemakers H.F.J., Voorhorst F.J., Rozendaal L., Nobbenhuis M.A.E., et al. Human papillomavirus 16 load in normal and abnormal cervical scrapes: an indicator of CIN II/III and viral clearance. Int J Cancer 98 (2002) 590-595
44. Klein R.S., Ho G.Y.F., Vermund S.H., Fleming I., and Burk R.D. Risk factors for squamous intraepithelial lesions on pap smear in women at risk for human immunodeficiency virus infection. J Infect Dis 170 (1994) 404-409
45. Sun C.A., Lai H.C., Chang C.C., Neih S., Yu C.P., and Chu T.Y. The significance of human papillomavirus viral load in prediction of histologic severity and size of squamous intraepithelial lesions of uterine cervix. Gyn Oncol 83 (2001) 95-99
46. Sun C.A., Liu J.F., Wu D.M., Nieh S., Yu C.P., and Chu T.Y. Viral load of high-risk human papillomavirus in cervical squamous intraepithelial lesions. Int J Gynaecol Obstet 76 (2002) 41-47
47. Beskow A.H., and Gyllensten U.B. Host genetic control of HPV 16 titer in carcinoma in situ of the cervix uteri. Int J Cancer 101 (2002) 526-531
48. Cheung J.L., Lo K.W., Cheung T.H., Tang J.W., and Chan P.K. Viral load, E2 gene disruption status, and lineage of human papillomavirus type 16 infection in cervical neoplasia. J Infect Dis 194 (2006) 1706-1712
49. Guo M., Sneige N., Silva E.G., Jan Y.J., Cogdell D.E., Lin E., et al. Distribution and viral load of eight oncogenic types of human papillomavirus (HPV) and HPV 16 integration status in cervical intraepithelial neoplasia and carcinoma. Mod Pathol 20 (2007) 256-266
50. Mayrand M.H., Coutlee F., Hankins C., Lapointe N., Forest P., De Ladurantaye M., et al. Detection of human papillomavirus type 16 DNA in consecutive genital samples does not always represent persistent infection as determined by molecular variant analysis. J Clin Microbiol 38 (2000) 3388-3393